Clinical trial
Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in…
NCT00096746 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00096746 |
|---|---|
| Title | Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects |
| Official title | An Exploratory Study of the Effect of the Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | LPV/RTV + 2NRTIs |
| Enrollment | 200 |
| Start date | Nov 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Nov 16, 2004 |
| Last update posted | Apr 13, 2011 |
| Countries | Argentina, Brazil, Guatemala, Mexico, Peru, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: